characteris
new
virus
often
hinder
difficulti
amplifi
cell
cultur
limit
antigen
serolog
crossreact
lack
nucleic
acid
hybridis
known
viral
sequenc
numer
molecular
method
use
genet
characteris
new
virus
without
prior
vitro
replic
use
virusspecif
reagent
recent
metagenom
studi
viral
particl
uncultur
environment
clinic
sampl
purifi
nucleic
acid
randomli
amplifi
prior
subclon
sequenc
alreadi
known
novel
virus
identifi
compar
translat
sequenc
viral
protein
public
sequenc
databas
metagenom
approach
viral
characteris
appli
seawat
near
shore
sediment
faec
serum
plasma
respiratori
secret
broaden
rang
known
viral
divers
select
sampl
high
viral
load
purif
viral
particl
remov
cellular
nucleic
acid
effici
sequenceindepend
amplif
viral
rna
dna
recognis
sequenc
similar
known
viral
sequenc
deep
sampl
nucleic
acid
popul
larg
scale
sequenc
improv
yield
new
virus
review
list
anim
virus
recent
identifi
use
sequenceindepend
method
current
laboratori
bioinformat
method
togeth
limit
potenti
improv
viral
metagenom
approach
provid
novel
opportun
gener
unbias
characteris
viral
popul
variou
organ
environ
therefor
plasma
serum
respiratori
secret
cerebrospin
fluid
urin
faec
filter
environment
sampl
appropri
viral
metagenom
studi
e
l
delwart
e
l
delwart
classic
method
use
identif
virus
includ
vitro
viral
amplif
follow
electron
microscopi
use
refer
serum
previous
infect
vaccin
host
cell
cultur
combin
visual
observ
cytopath
effect
follow
test
immunolog
crossreact
use
larg
panel
sera
power
rel
rapid
method
unknown
viral
agent
replic
particular
cell
line
use
crossreact
reagent
avail
tent
identif
viru
allow
use
specif
reagent
particularli
degener
pcr
primer
target
like
viral
group
definit
genet
characteris
strictli
molecular
method
requir
vitro
replic
scarc
serolog
antigen
reagent
also
develop
success
use
allow
characteris
numer
novel
anim
virus
method
describ
special
emphasi
sequenceindepend
amplif
plasmid
librari
sequenc
nucleic
acid
biolog
fluid
environment
sampl
collect
refer
viral
metagenom
divers
bacteriophag
obtain
seawat
viral
particl
found
level
high
per
litr
surfac
seawat
nearshor
sediment
human
faec
recent
review
pioneer
group
rapidli
grow
field
viral
metagenom
emerg
previous
unrecognis
virus
result
improv
transmiss
opportun
andor
adapt
mutat
underlin
need
better
characteris
full
rang
virus
replic
human
ie
human
virom
highli
preval
infect
anellovirus
gbvc
shown
human
recent
identif
two
highli
common
chronic
human
infect
use
molecular
method
hint
possibl
wider
human
viral
flora
initi
thought
induc
hepat
two
divers
viral
group
thought
larg
commens
recent
identifi
pathogen
virus
appar
strictli
human
origin
includ
norwalk
noroviru
gastroenter
outbreak
human
herpesviru
case
kaposi
sarcoma
aid
patient
metapneumoviru
children
wide
rang
respiratori
symptom
new
human
coronaviru
new
human
parvoviru
improv
ecolog
opportun
seen
larg
number
immunocompromis
aid
patient
increas
incid
patholog
infect
virus
jcv
human
polyomaviru
provid
fertil
ground
viru
spread
evolut
newli
characteris
human
virus
unknown
pathogen
includ
anoth
recent
identifi
parvoviru
new
anelloviru
variant
blood
febril
patient
frequent
viral
epidem
crowd
domest
anim
popul
well
wild
anim
potenti
spillov
effect
human
popul
emphasis
need
epidem
surveil
anim
origin
chimpanze
sooti
mangabey
respect
thought
enter
human
popul
last
centuri
hunt
consumpt
nonhuman
primat
nhp
central
african
bushhunt
shown
infect
simian
foami
viru
well
relat
retroviru
newli
characteris
nhp
worker
us
show
sign
infect
simian
foami
virus
defer
blood
donor
canada
virus
recent
transmit
anim
human
includ
sar
coronaviru
civet
cat
whose
infect
may
origin
bat
west
nile
viru
north
america
mosquito
feed
infect
bird
influenza
throughout
asia
influenza
holland
poultri
handl
hantavirus
rodent
urin
sw
region
us
start
ebola
viru
nhp
possibl
infect
bat
democrat
republ
congo
sudan
late
monkeypox
virus
african
rodent
pet
midwestern
us
nipah
viru
human
pig
malaysia
also
possibl
transmit
infect
bat
characteris
virus
highli
expos
popul
inject
drug
user
central
african
bushhunt
zoo
nhp
facil
worker
highli
suscept
popul
aid
immunocompromis
transplant
patient
use
nonbias
method
may
use
surveil
tool
earli
detect
emerg
viral
infect
larg
scale
viral
metagenom
analysi
less
expos
easili
obtain
voluntari
blood
donor
mean
viru
surveil
propos
molecular
analys
sampl
patient
suffer
symptom
unknown
aetiolog
possibl
infecti
origin
recent
yield
new
human
virus
larg
fraction
enceph
hepat
gastrointestin
diseas
myocard
well
autoimmun
diseas
may
associ
infect
yet
unknown
virus
multipl
cancer
recognis
result
viral
infect
ie
hbv
hcv
hpv
hiv
ebv
also
conceiv
yet
uncharacteris
virus
involv
form
tumorgenesi
feder
state
programm
us
european
commun
well
numer
countri
activ
collect
specimen
symptomat
well
highli
expos
human
popul
test
known
infecti
agent
similar
studi
domest
wild
anim
popul
may
also
identifi
newli
emerg
establish
virus
potenti
caus
econom
environment
problem
crossov
expos
human
microarray
spot
viral
sequenc
oligonucleotid
use
genet
charateris
sarscov
cell
cultur
supernat
novel
retroviru
frozen
human
prostat
tissu
microarray
provid
power
tool
viral
discoveri
provid
new
virus
suffici
relat
alreadi
known
permit
specif
hybridis
degener
pcr
primer
base
conserv
sequenc
within
viral
group
impress
track
record
identifi
numer
macaqu
herpesvirus
gbvc
hcovnh
anim
retrovirus
picornavirus
seawat
approach
limit
viral
group
requir
use
differ
degener
primer
set
use
highli
degener
primer
highli
variabl
viral
group
express
librari
gener
use
sequenceindepend
amplif
method
also
gener
screen
use
seroposit
plasma
result
identif
hcv
gbvc
screen
use
viru
enrich
label
nucleic
acid
probe
yield
borna
diseas
viru
power
librari
screen
method
therefor
requir
use
specif
reagent
antibodi
unknown
viru
alreadi
known
present
number
relat
method
term
subtract
hybridis
represent
differ
analysi
rda
involv
dna
hybridis
tester
nucleic
acid
infect
tissu
uninfect
driver
nucleic
acid
viral
nucleic
acid
select
amplifi
sever
round
hybridis
purif
unhybridis
singl
strand
tester
nucleic
acid
use
hydroxapatit
chromatographi
follow
subclon
plasmid
express
antigen
interest
may
identifi
immunoreact
appropri
serum
antibodi
sequenc
homolog
known
virus
rda
therefor
requir
infect
noninfect
tissu
individu
follow
multipl
cycl
hybridis
pcr
reamplif
result
preferenti
amplif
sequenc
uniqu
tester
sampl
rda
led
discoveri
ttv
gbva
b
subtract
hybridisationbas
techniqu
requir
larg
amount
infect
uninfect
materi
person
technic
demand
therefor
limit
number
sampl
analys
biolog
sampl
avail
suspect
natur
viru
dictat
appropri
method
viru
discoveri
conceptu
relat
set
method
reli
sequenceindepend
amplif
subclon
sequenc
purifi
viral
nucleic
acid
follow
silico
search
sequenc
similar
known
virus
appli
environment
collect
sampl
unmanipul
biolog
sampl
approach
label
viral
metagenom
term
viral
metagenom
may
also
loos
use
describ
gener
approach
nonspecif
amplif
sequenc
viral
nucleic
acid
cell
cultur
supernat
presenc
unknown
viru
suspect
base
appear
cellular
cytopath
effect
primari
advantag
sequenceindepend
amplif
sequenc
method
characteris
novel
virus
simplic
rel
speed
lack
bia
toward
particular
viral
group
requir
specif
reagent
abil
detect
new
virus
highli
diverg
alreadi
known
conserv
protein
motif
limit
sequenceindepend
nucleic
acid
amplif
method
viral
discoveri
gener
unsuit
sampl
host
nucleic
acid
viral
nucleic
acid
easili
separ
tissu
biopsi
pbmc
sinc
result
fraction
viral
sequenc
rel
host
nucleic
acid
would
extrem
low
studi
cellular
sampl
use
microarray
degener
primer
pcr
subtract
hybridis
may
appropri
sequenceindepend
nucleic
acid
amplif
method
particularli
use
studi
sampl
cell
easili
filter
residu
host
nucleic
acid
remov
enzymat
digest
viral
genet
materi
remain
protect
within
viral
capsid
sequenceindepend
singl
primer
amplif
sispa
sispa
origin
develop
amplifi
low
copi
number
nucleic
acid
human
genom
applic
sispa
base
endonucleas
restrict
target
dna
follow
ligat
adaptor
linker
complementari
overhang
base
target
dna
rna
virus
also
amplifi
sispa
follow
random
prime
cdna
synthesi
follow
dsdna
synthesi
use
dna
polymeras
activ
revers
transcriptas
follow
rnase
h
digest
rna
compon
rnadna
hybrid
pcr
primer
complementari
ligat
linker
use
amplifi
sequenc
locat
pair
restrict
site
sispa
combin
immunoscreen
express
clone
use
genet
characteris
norwalk
viru
faec
human
astroviru
cultur
supernat
hepat
e
viru
hev
also
clone
use
method
combin
differenti
hybridis
label
nucleic
acid
infect
noninfect
tissu
identifi
viral
subclon
genet
characteris
new
human
coronaviru
cultur
supernat
perform
use
two
differ
sispa
primer
anneal
differ
restrict
site
follow
second
round
pcr
use
primer
extra
base
limit
amplif
subset
origin
amplif
product
modif
sispa
recent
review
dnasesispa
modif
sispa
plasma
sampl
first
filter
remov
bacteria
eukaryot
cell
size
particl
treat
dnase
remov
contamin
human
nake
dna
remain
viral
nucleic
acid
protect
within
capsid
extract
dna
rna
follow
convers
dsdna
use
random
primer
amplifi
sispa
amplif
product
subclon
plasmid
insert
sequenc
analys
sequenc
similar
known
virus
method
success
identifi
new
parvovirus
bovin
sera
human
plasma
relat
method
physic
shear
dsdna
purifi
virus
random
site
use
hydroshear
genom
solut
inc
repair
rag
end
dna
polymeras
polynucleotid
kinas
ligat
defin
sequenc
linker
extrem
use
primer
complementari
linker
pcr
amplifi
dna
fragment
prior
plasmid
subclon
first
purifi
viral
rna
perform
dsdna
synthesi
method
also
recent
appli
rna
virus
seawat
lasl
sispa
relat
method
nucleic
acid
nonspecif
pcr
amplifi
attach
linker
ligat
random
site
versu
endonucleas
restrict
site
simpl
method
typic
use
analys
differ
complex
genom
strain
staphylococcu
detect
differ
mrna
express
profil
take
advantag
abil
arbitrarili
design
pcr
primer
initi
pcr
mani
differ
site
complex
mixtur
nucleic
acid
anneal
low
temperatur
use
singl
pcr
primer
pair
whose
exact
sequenc
arbitrari
first
round
pcr
perform
c
allow
primer
initi
pcr
mani
partial
complementari
site
follow
pcr
cycl
perform
stringent
anneal
temperatur
c
pcr
product
typic
analys
denatur
gel
electrophoresi
detect
differ
band
pattern
also
directli
subclon
sequenc
method
use
clone
new
human
pneumoviru
cell
cultur
supernat
method
base
theoret
amplif
nucleic
acid
present
use
pcr
primer
random
nucleotid
sequenc
end
size
n
defin
sequenc
end
rna
virus
revers
transcript
first
perform
primer
low
anneal
temperatur
c
allow
randomli
prime
cdna
extens
anoth
singl
round
extens
primer
perform
follow
denatur
cdnarna
hybrid
primer
anneal
low
temperatur
follow
klenow
dna
polymeras
extens
use
pcr
primer
complementari
defin
initi
primer
cycl
pcr
perform
high
anneal
temperatur
dna
target
amplif
two
round
low
temperatur
anneal
primer
extens
perform
random
pcr
use
defin
sequenc
primer
random
pcr
method
choic
amplifi
label
probe
fluoresc
dye
microarray
analysi
random
pcr
use
characteris
new
human
parvoviru
identifi
numer
known
rna
dna
virus
respiratori
secret
tabl
amplifi
rna
dna
virus
cell
cultur
identifi
short
dna
sequenc
sequenc
similar
genbank
whose
preval
plasma
higher
nona
hepat
control
patient
genom
field
often
limit
amount
start
dna
avail
properti
polymeras
make
possibl
amplifi
entir
human
genom
start
littl
cell
mg
dna
isotherm
produc
method
base
abil
bacteriophag
dna
polymeras
effici
displac
anneal
dna
strand
front
advanc
end
coupl
long
process
base
result
multipl
displac
amplif
reaction
figur
dna
polymeras
prime
modifi
random
hexam
oliogonucleotid
resist
exonucleas
activ
singl
dna
strand
gener
use
templat
figur
method
achiev
unbias
amplif
everi
human
locu
analys
figur
high
proof
read
abil
dna
polymeras
also
reduc
artifactu
mutat
use
dna
polymeras
base
amplif
viral
discoveri
recent
report
success
amplifi
circular
dna
anelloviru
method
success
amplifi
numer
circular
dna
viral
genom
polymeras
come
full
circl
circular
viral
genom
displac
end
continu
extend
new
strand
multipl
time
around
dna
circl
random
primer
anneal
displac
strand
convert
doubl
strand
dna
long
dsdna
product
cut
restrict
enzym
expect
cut
within
circl
sequenc
releas
linear
fragment
length
circl
figur
techniqu
gener
use
amplifi
plasmid
librari
recent
use
amplifi
circular
genom
human
papillomavirus
cervic
keratinocyt
cell
line
fibropapillomat
wart
florida
manate
rca
initi
random
primer
dna
variou
organ
also
yield
full
genom
sequenc
polyomavirus
anelloviru
circovirus
geminivirus
plant
begomoviru
wasp
polydnaviru
cdna
librari
posttranspl
lymphoprolif
disord
tissu
similarli
analys
ebv
sequenc
identifi
among
human
cdna
sequenc
approach
reli
sequenc
data
gather
purpos
yield
viral
sequenc
low
due
predomin
human
sequenc
key
metagenom
base
viral
discoveri
increas
level
viral
nucleic
acid
reduc
background
prokaryot
eukaryot
nucleic
acid
environment
sampl
avail
larg
volum
seawat
viru
concentr
reduct
background
nucleic
acid
prokaryot
eukaryot
cell
perform
three
complementari
approach
viral
nucleic
acid
purif
prior
amplif
use
filtrat
densiti
gradient
centrifug
enzymat
remov
nonparticl
protect
nucleic
acid
larg
bodi
literatur
report
remov
viral
particl
manufactur
blood
deriv
biolog
use
filter
pore
size
small
nm
purpos
concentr
viral
nucleic
acid
filtrat
pore
size
nm
initi
use
remov
bacteria
eukaryot
larg
aggreg
sinc
largest
known
viru
mimiviru
nm
diamet
size
compar
small
bacterium
filter
size
repres
compromis
expect
allow
flow
largest
virus
filtrat
concentr
virus
use
start
sampl
volum
larg
faec
seawat
studi
analys
seawat
dna
bacteriophag
use
tangenti
flow
filtrat
cutoff
mr
concentr
viral
particl
prior
ultracentrifug
cesium
chlorid
step
gradient
collect
gml
dna
phage
densiti
fraction
cscl
densiti
gradient
ultracentrifug
also
use
directli
plasma
pool
purif
human
dna
virus
ultrafiltr
use
tangenti
flow
filter
cutoff
mr
also
use
purifi
virus
filter
seawat
follow
ultracentrifug
pellet
virus
follow
initi
larg
particl
remov
filtrat
viral
particl
purifi
lower
densiti
materi
centrifug
sucros
solut
resuspens
viral
pellet
overal
strategi
larg
volum
sampl
therefor
initi
filtrat
remov
bacteria
size
particl
follow
concentr
small
pore
size
filter
mr
reduc
volum
follow
high
speed
centrifug
sucros
cesium
chlorid
gradient
noncoval
bound
histon
therefor
major
sourc
background
dna
use
total
nucleic
acid
amplif
approach
dnase
treatment
report
alland
et
al
key
factor
remov
host
dna
serum
prior
sispa
amplif
viral
nucleic
acid
dnase
treatment
thought
remov
nake
dna
exonucleas
digest
dna
within
viral
capsid
within
lipid
bilay
case
envelop
virus
shield
enzymat
activ
similar
treatment
use
rnase
use
remov
access
rna
viral
concentr
faec
seawat
subsequ
dnase
rnase
treatment
capsid
protect
viral
nucleic
acid
purifi
use
guanidinium
isocyan
protein
denatur
follow
nucleic
acid
bind
silica
eg
qiagen
viral
rna
purif
phenolchloroform
extract
follow
ethanol
isopropanol
precipit
ctab
cation
deterg
extract
focu
restrict
dna
rna
virus
extract
nucleic
acid
digest
appropri
nucleas
addit
step
reduc
nonvir
background
nucleic
acid
treat
cscl
band
virus
dilut
chloroform
disrupt
mitochondri
membran
expos
dna
enzymat
degrad
howev
may
disrupt
stabil
lipid
envelop
virus
softwar
web
site
gener
contig
overlap
sequenc
variabl
number
mismatch
due
variant
viral
speci
start
hundr
hundr
thousand
input
sequenc
use
pyrosequenc
exist
requir
high
level
user
expertis
use
comput
demand
search
algorithm
tblastx
detect
lowlevel
translat
protein
similar
known
viral
sequenc
also
time
consum
criterion
classifi
sequenc
viruslik
sequenc
also
arbitrari
tblastx
e
score
known
viral
sequenc
frequent
use
defin
sequenc
viral
origin
although
other
use
stringent
cutoff
e
fundament
problem
detect
presenc
novel
viral
sequenc
highli
diverg
current
databas
sequenc
similar
readili
detect
use
tblastx
larg
fraction
sequenc
deriv
anim
sampl
sequenceindepend
amplif
method
even
greater
fraction
sequenc
deriv
environment
sampl
show
signific
nucleotid
amino
acid
sequenc
similar
sequenc
includ
virus
current
genbank
origin
nucleic
acid
therefor
great
interest
potenti
repres
novel
highli
distinct
virus
sever
approach
may
improv
identif
highli
diverg
viral
sequenc
search
conserv
protein
motif
expect
help
identifi
distantli
relat
viral
protein
sequenc
sinc
viral
group
posit
strand
rna
virus
encod
number
recognis
core
protein
function
viral
hallmark
gene
encod
viral
function
found
wide
divers
viru
group
distant
homologu
cell
whose
origin
may
predat
cellular
life
exampl
gene
encod
jellyrol
capsid
protein
structur
superfamili
helicas
function
found
larg
small
dna
rna
virus
search
among
annot
weak
similar
match
viral
hallmark
gene
keyword
could
also
focu
amplif
sequenc
effort
potenti
viral
sequenc
use
substitut
matric
use
quantifi
protein
sequenc
similar
gener
viral
rather
eukaryot
prokaryot
protein
align
may
also
improv
detect
lowlevel
similar
current
viral
sequenc
comput
gener
theoret
ancestr
sequenc
numer
extant
viral
group
subsequ
use
sequenc
similar
search
may
also
improv
identif
highli
diverg
viral
sequenc
sinc
genet
distanc
new
virus
common
ancestor
extant
speci
reduc
bioinformat
improv
could
also
base
search
particular
rna
fold
relat
frequent
found
rna
virus
viroid
rna
silico
protein
structur
predict
use
linear
nucleic
acid
sequenc
although
yet
commonli
feasibl
may
also
improv
detect
diverg
virus
encod
conserv
viral
protein
structur
method
independ
blast
base
align
predict
rna
protein
structur
base
similar
would
also
assist
discrimin
among
unclassifi
sequenc
like
viral
versu
bacteri
archaeal
eukaryot
origin
dinucleotid
sequenc
analysi
take
advantag
composit
bias
sequenceindepend
fashion
establish
genom
signatur
biolog
pressur
influenc
genom
composit
shown
predict
evolutionari
diverg
exampl
cg
dinucleotid
underrepresent
vertebr
rel
bacteria
attribut
high
level
cpg
methyl
differ
dinucleotid
frequenc
use
success
identifi
region
horizont
gene
transfer
among
bacteria
discrimin
exon
intron
region
human
sequenc
differenti
bacteri
plasmid
phage
sequenc
viru
genom
persist
uniqu
pressur
affect
nucleotid
composit
rapid
rate
replic
propos
decreas
cg
dinucleotid
due
unfavour
high
thermodynam
stack
energi
antivir
host
factor
cytosin
deamin
caus
g
mutat
hiv
mold
genom
composit
virus
dinucleotid
composit
therefor
anoth
potenti
tool
help
discrimin
viral
sequenc
select
among
unclassifi
sequenc
virallik
dinucleotid
composit
studi
analysi
tetranucleotid
frequenc
also
use
discrimin
among
sequenc
differ
bacteri
speci
although
use
short
contig
typic
gener
viral
metagenom
may
problemat
laboratorybas
approach
identifi
highli
diverg
viral
sequenc
search
close
relat
nucleic
acid
repeatedli
found
differ
anim
human
sampl
detect
close
relat
yet
unclassifi
nucleic
acid
differ
individu
particularli
contain
long
open
read
frame
may
reflect
presenc
highli
preval
virus
identif
preval
sequenc
may
target
shotgun
sequenc
specif
chromosom
walk
particular
sampl
sequenc
order
gener
larger
contigu
sequenc
allow
even
weaker
sequenc
structur
similar
detect
transmiss
ongo
replic
unclassifi
nucleic
acid
may
also
determin
analys
blood
transfus
recipi
appear
mainten
unclassifi
nucleic
acid
found
transfus
blood
flank
sequenc
walk
acquisit
full
viral
genom
purpos
metagenom
analysi
descript
complet
nearli
complet
new
viral
genom
high
frequenc
viral
nucleic
acid
rel
amplifi
nucleic
acid
requir
gener
larg
contig
overlap
sequenc
sampl
contain
low
viral
concentr
yield
singl
virallik
sequenc
may
analys
simpli
increas
sampl
nucleic
acid
mixtur
ie
sequenc
librari
subclon
use
novel
technolog
pyrosequenc
improv
viral
particl
purif
sequenc
cost
limit
sampl
avail
particularli
rare
clinic
sampl
may
preclud
approach
requir
initi
sequenc
match
known
virus
extend
larger
sequenc
use
sequencespecif
extens
method
two
subclon
show
signific
sequenc
similar
match
differ
region
viru
region
may
link
simpli
use
long
distanc
specif
pcr
singl
subclon
show
signific
similar
known
viru
genet
foothold
may
serv
region
hybridis
specif
primer
acquir
flank
sequenc
data
use
rapid
amplif
cdna
end
race
chromosom
walk
method
reli
linear
pcr
amplif
use
singl
specif
primer
bound
initi
foothold
region
follow
low
temperatur
anneal
singl
randomli
chosen
primer
pcr
first
nonspecif
bind
primer
extend
follow
use
specif
primer
ligat
adaptor
linker
end
dsdna
follow
pcr
use
linker
foothold
specif
primer
base
format
dna
circl
invers
pcr
use
specif
primer
rca
take
place
may
also
use
acquir
flank
viral
sequenc
replica
plate
randomli
specif
gener
plasmid
escherichia
coli
librari
may
also
probe
coloni
southern
hybridis
use
initi
viral
match
sequenc
label
probe
tradit
coloni
lift
method
pcr
screen
identifi
e
coli
subclon
contain
initi
viru
match
sequenc
flank
region
therebi
fraction
viral
genom
plasmid
librari
may
also
screen
specif
insert
selflig
invers
pcr
product
deriv
plasmid
librari
base
strictli
sequenc
similar
known
virus
number
anim
virus
recent
identifi
alland
et
al
initi
characteris
two
novel
parvovirus
bovin
sera
use
dnasesispa
studi
human
plasma
febril
patient
use
dnasesispa
nasopharyng
secret
patient
respiratori
symptom
use
random
pcr
identifi
alreadi
known
dna
rna
virus
well
two
new
human
parvovirus
human
bocaviru
tabl
new
parvovirus
sinc
repeatedli
detect
case
hbov
shown
common
infant
respiratori
pathogen
studi
virus
plasma
healthi
adult
use
dna
polymeras
amplif
lasl
identifi
numer
divers
anellovirus
well
signific
match
tblastx
potenti
new
viral
sequenc
metagenom
studi
human
faec
use
lasl
focus
dna
virus
identifi
numer
dsdna
siphophag
whose
gram
posit
bacteri
host
make
major
bacteri
cell
human
fece
later
studi
human
fece
use
sispa
target
rna
virus
identifi
larg
number
plant
viral
pathogen
larg
major
sequenc
belong
pepper
mild
mottl
viru
analysi
equin
fece
dna
viru
use
lasl
indic
subclon
show
similar
genbank
sequenc
greater
half
remain
sequenc
also
relat
siphophag
use
rca
numer
circular
viral
dna
genom
characteris
blood
tissu
fece
mammal
bird
insect
plant
landmark
paper
breitbart
et
al
analys
viral
commun
present
seawat
start
litr
seawat
virus
first
purifi
differenti
filtrat
step
gradient
cscl
densiti
ultracentrifug
plasmid
librari
construct
use
lasl
dna
shear
pcr
amplif
rather
direct
subclon
use
disrupt
potenti
toxic
viral
gene
remov
modifi
base
often
present
bacteriophag
dna
clone
directli
e
coli
sixti
five
per
cent
sequenc
deriv
linkeramplifi
shotgun
librari
relat
sequenc
databas
tblastx
e
score
extrapol
sequenc
subclon
number
sequenc
overlap
number
identifi
viral
sequenc
seawat
estim
number
new
viral
type
depend
contig
assembl
stringenc
thirtyforti
per
cent
signific
tblastx
hit
e
score
phage
sequenc
follow
repeat
mobil
element
bacteria
archaea
eukarya
sequenc
base
genbank
annot
figur
similar
studi
dsdna
virus
near
shore
sediment
indic
much
phylogenet
viral
metagenom
viral
metagenom
overlap
seawat
bacteriophag
presenc
least
distinct
genotyp
per
kilogram
sediment
unlik
find
group
use
human
faecal
matter
bacteriophag
known
infect
gram
posit
bacteria
almost
complet
absent
marin
sampl
recent
studi
seawat
purifi
concentr
viral
particl
success
filter
step
remov
cellular
organ
prior
pellet
virus
ultracentrifug
resuspend
pellet
treat
rnase
prior
extract
nucleic
acid
protect
within
viral
particl
extract
nucleic
acid
treat
dnase
remov
viral
dna
viral
rna
revers
transcrib
use
random
hexam
primer
dsdna
gener
use
rnase
h
e
coli
dna
polymeras
doubl
strand
dna
treat
manner
similar
lasl
approach
yield
sequenc
without
sequenc
similar
genbank
among
tblastx
relat
posit
strand
ssrna
virus
rna
bacteriophag
detect
indic
marin
bacteriophag
dna
genom
host
marin
rna
virus
may
eukaryot
sequenc
resembl
virus
known
infect
higher
plant
insect
detect
alongsid
new
picornalik
virus
whose
domin
seawat
viral
popul
allow
genom
complet
assembl
viral
metagenom
studi
environment
anim
sampl
appear
pois
rapid
growth
driven
larg
improv
viral
particl
purif
method
reduc
cost
dna
sequenc
rapidli
grow
viral
sequenc
databas
improv
bioinformat
tool
small
genom
size
virus
allow
new
genom
assembl
limit
shotgun
sequenc
data
aid
case
specif
pcr
amplif
base
initi
partial
viral
genom
data
like
new
technolog
rapidli
impact
field
particularli
multiplex
sequenc
method
pyrosequenc
poloni
sequenc
larg
restrict
bacteri
metagenom
analysi
sampl
low
level
highli
degrad
dna
frozen
mammoth
neanderth
bone
develop
softwar
detect
lowlevel
sequenc
similar
greatli
aid
data
analysi
use
multiplex
sequenc
tool
gener
short
sequenc
read
bp
per
experi
also
necessit
improv
methodolog
use
search
lowlevel
protein
sequenc
rna
structur
similar
develop
viru
specif
blosum
matric
use
measur
similar
distantli
relat
protein
use
predict
ancestr
sequenc
may
also
improv
detect
highli
diverg
virus
develop
method
analys
metagenom
data
use
dior
trinucleotid
sequenc
composit
develop
molecular
biolog
reagent
certifi
free
amplifi
nucleic
acid
particularli
bacteria
also
reduc
background
nois
sequenceindepend
amplif
method
exampl
detect
murin
leukemia
viru
revers
transcriptas
nucleic
acid
commerci
revers
transcriptas
enzym
prepar
well
sequenc
belong
wide
use
agricultur
use
viral
insect
pest
control
agent
autographa
californica
nucleopolyhedroviru
protein
reagent
like
reflect
commerci
reagent
contamin
collect
analysi
appropri
sampl
clinic
case
diseas
possibl
unidentifi
viral
aetiolog
key
rapid
identif
new
viral
pathogen
use
metagenom
sampl
collect
earli
rel
onset
diseas
febril
episod
prior
specif
symptom
onset
might
contain
highest
viral
load
facilit
viru
identif
sampl
highli
expos
popul
inject
drug
user
infect
suscept
group
aid
patient
immunosupress
transplant
recipi
also
help
defin
human
virom
surveil
anim
viru
transmiss
human
popul
help
studi
expos
african
bushhunt
worker
expos
nhp
anim
studi
virus
anim
wild
domest
environment
chang
crowd
condit
may
acceler
viru
transmiss
evolut
also
ripe
applic
viral
metagenom
techniqu
viral
metagenom
viral
metagenom
increas
use
sequenceindepend
amplif
effici
sequenc
methodolog
seem
like
new
viral
speci
identifi
rate
consider
greater
knowledg
biolog
determin
whether
newli
identifi
virus
pathogen
even
subset
infect
togeth
mode
transmiss
replic
strategi
host
cell
may
requir
largescal
epidemiolog
well
anim
detail
virolog
studi
signific
fraction
everevolv
cast
virus
infect
human
anim
pathogen
commens
may
still
remain
uncharacteris
viral
metagenom
analys
appropri
human
anim
sampl
assist
genet
characteris
virus
facilit
subsequ
studi
pathogen
possibl
mean
control
